Bioblast Pharma Ltd. (ORPN) gained 7.51% or 0.16 to $2.29. It is close to 10732 shares traded, which is 43.58% compare to the average total volume 24626. The market cap of ORPN is $7.65 million. The year to date change is -4.05%. The 52 week price range is from $1.49 to $5.99. Price of ORPN have changed -2.74% during last week. It have changed 4.93% over last month, -22.26% over last 3 months, -1.84% over last 6 months and -19.62% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ORPN is 2.39. It is 4.37% above current price. The 200-day Moving Averages for ORPN is 2.55. It is 11.35% above current price. The 52-week High is 5.99. It is 161.57% from the current price. The 52-week Low is 1.49. It is -34.93% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ORPN is 4.35 on 2018-04-13. Short % to float is 4.44%. There are some statistics of ORPN. It is has market cap $7.65 million. The share outstanding is 3.34 million. The average volume is 24626. The percent of top 15 Institution holding is 6.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ORPN is -100.24%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ORPN is -83.43%.